Four-stranded G-quadruplex nucleic acid structures have been of great interest as their high thermodynamic stability under near-physiological conditions suggests that they could form in cells. Here, we report the generation and application of an engineered, structure-specific antibody that was employed to visualize quantitatively DNA G-quadruplex structures in human cells. We explicitly show that G-quadruplex formation in DNA is modulated during cell cycle progression and that endogenous G-quadruplex DNA structures can be stabilized by a small molecule ligand. Together these findings provide substantive evidence for the formation of G-quadruplex structures in the genome of mammalian cells and corroborate the application of stabilizing ligands in a cellular context to target G-quadruplexes and intervene with their function.
predicted G-quadruplex motifs are binding sites for the helicases ATRX (alpha thalassemia/ mental retardation syndrome X-linked) and PIF1 18, 19 . Our recent genome-wide study has also shown that a stabilizing small molecule, pyridostatin (PDS), induces DNA damage at sites enriched in G-quadruplex motifs and that PIF1 is likely to resolve these structures in vivo 5 . An important breakthrough in the field was the visualization of G-quadruplex structures at the telomeres of ciliate macronuclei in which the millions of telomeres enabled fluorescent imaging with an antibody, and revealed the cell cycle-dependent formation of telomeric G-quadruplexes [20] [21] [22] . Up to now, it has remained an important challenge to visualize G-quadruplex structures in the DNA of mammalian cells.
Herein, we describe an engineered, structure-specific antibody probe that binds with high selectivity and low nanomolar affinity to DNA G-quadruplex structures. The G-quadruplexspecific antibody was then employed to visualize DNA G-quadruplex structures in the genomic DNA of human cells. We have also characterized the relationship between the cell cycle and G-quadruplex formation and have demonstrated that a small molecule Gquadruplex ligand stabilizes these structures in cells.
Results and discussion
To generate a G-quadruplex-specific antibody, we employed phage display with a library of 2.3 × 10 10 different single-chain antibody clones 23 . Through in vitro selection for Gquadruplex structures, the best hit amongst the selected binders, called BG4, was isolated for further studies. Using ELISA (enzyme-linked immunosorbent assay) methods, we showed that BG4 has high affinity for intramolecular and intermolecular DNA G-quadruplexes (K d 0.5 -1.6 nM, and 2.0 nM respectively) with no detectable binding to a RNA hairpin, singlestranded or double-stranded DNA (Fig. 1) . To evaluate the affinity of BG4 for different structural conformations, we investigated binding to parallel propeller (MYC, KIT1 and KIT2), anti-parallel (SPB1 and TBA), mixed parallel/anti-parallel propeller (hTELO) and intermolecular (intermolec hTELO) G-quadruplex structures ( Supplementary Fig. S1 ). Given the similarities in binding affinities, these results indicate that BG4 is a G-quadruplex structure-specific antibody that does not have a preference for any particular structural conformation. We next characterized BG4 specificity for G-quadruplexes over other nucleic acid structures in competition experiments. Up to 50-fold excess of different competitors were pre-incubated with the BG4 antibody before assessment of binding to the MYC Gquadruplex by ELISA. In no case we observed significant inhibition of binding to the target G-quadruplex by yeast tRNA, double-stranded poly (GC) n or poly (AT) n , sonicated doublestranded salmon sperm DNA, or a RNA hairpin oligonucleotide. Competition was only achieved using a positive control KIT1 G-quadruplex oligonucleotide (Supplementary Fig.  S2 ). Collectively, these experiments robustly support the specificity of the BG4 antibody for G-quadruplex structures.
BG4 was then used to visualize DNA G-quadruplex structures in human cells. After incubation of fixed cells with BG4, sensitive detection was achieved through an amplified fluorescence signal generated by incubation with a secondary antibody then a tertiary fluorochrome-labelled antibody. All cell lines examined showed punctate nuclear staining ( Fig. 2a and Supplementary Figs. S3 ) not observed in the absence of primary BG4 antibody ( Supplementary Fig. S3 ). The specificity of BG4 for G-quadruplexes was confirmed by loss of signal upon pre-incubation of the antibody with excess pre-folded G-quadruplex oligonucleotides, but without signal loss upon pre-incubation with single-stranded oligonucleotides ( Fig. 2b and Supplementary Fig. S3 ). The G-quadruplex foci also disappeared after DNase treatment (Fig. 2c ), but not after RNase treatment ( Supplementary  Fig. S3 ). Moreover, the number of BG4 foci increased when cells were first transfected with pre-folded G-quadruplex oligonucleotides, but not when cells were transfected with single-stranded oligonucleotides (Fig. 2d and Supplementary Fig. S3 ). Taken together, these observations support the targeting and visualization of DNA G-quadruplex structures in human cells by BG4.
To further corroborate the detection of G-quadruplex structures in the cellular genome, we next assessed their distribution at the level of individual chromosomes ( Fig. 3a and Supplementary Fig. S4 ). To do this, we incubated BG4 with chromosomes prepared from cells treated with colcemid to block mitosis at metaphase, a stage of the cell cycle where individual chromosomes are most easily visualized. Figs. 3a iv and v clearly reveal BG4 localization at chromosomal ends confirming the presence of G-quadruplex structures at human telomeres. Furthermore, discrete BG4 foci were observed dispersed across chromosomes (Figs. 3a i, ii, iii), demonstrating that G-quadruplex structures also form outside the telomeric regions. Interestingly, in some cases, we observed symmetrical staining of sister chromatids (Fig. 3a v) , which supports G-quadruplex formation within the same genomic locations in newly replicated DNA. When the number of BG4 foci was quantified in 100 individual well-spread metaphase chromosomes, the majority (58%) of chromosomes had at least one site of BG4 staining and around a third displayed multiple foci ( Supplementary Fig. S4 ). When we scored positive BG4 staining chromosomes for telomeric distribution, we found that the majority (~75%) of BG4 foci were present outside telomeres ( Supplementary Fig. S4 ). Nonetheless, the observation that ~25% of foci were located at telomeres is evidence of site-specific localization of the BG4 antibody to a wellcharacterised site of G-quadruplex formation.
When fixed cells were co-stained for BG4 and TRF2 (telomere repeat-binding factor 2), a protein localized to telomeres, the majority of BG4 foci (82.4%) did not coincide with TRF2 foci (Fig. 3b ). This further suggests that endogenous G-quadruplex structures are largely present outside telomeres. It is notable that not all TRF2 foci co-localize with BG4 staining (36.8%) and not all metaphase chromosomes show telomeric BG4 staining. While these observations might indicate a differential propensity of disparate telomeres to form Gquadruplex structures, they may also be accounted by differences in antibody accessibility to the target (e.g. masking by telomere-binding proteins such as components of the protective shelterin complex).
We anticipated that G-quadruplex formation is more likely to occur during DNA replication, since the associated mechanisms necessitate that duplex strands become separated at replication forks, where single-stranded DNA may fold more easily into secondary structures 15 . To investigate this, we followed the formation of G-quadruplex structures during cell cycle progression. BG4 staining on synchronized cell populations showed lowest levels of G-quadruplex formation at G0/G1, a phase during which no replication occurs and cellular processes are quiescent. At the G1/S checkpoint, a time when cells prepare for entry into S phase, the period when DNA replication occurs, there was a ~ 2.5-fold increase in the number of BG4 foci. During S phase the number of BG4 foci was maximal (~ 4.8-fold more than at G0/G1), which is consistent with the replication-dependent formation of Gquadruplex structures (Figs. 4a, b) . To confirm that the increase in G-quadruplex structures observed during S phase was indeed dependent on DNA replication, we blocked cellular DNA synthesis with aphidicolin, a tetracyclic diterpene that specifically inhibits DNA polymerase α. As expected, aphidicolin treatment led to a large, over 2-fold, reduction in the number of BG4 foci (Figs. 4c, d ). These experiments demonstrate that G-quadruplex structures are modulated during the cell cycle in a way that is sensitive to whether or not the DNA is being replicated.
PDS to cells would result in the detection of more DNA G-quadruplex targets by the BG4 antibody. Indeed, when cells were treated with PDS, there was a marked increase (~ 2.9-fold) in nuclear staining (Figs. 5a, b ) that disappeared after DNase treatment ( Supplementary  Fig. S5 ). This increase is not due to a change of BG4 binding affinity for G-quadruplex structures in the presence of PDS, since we noted no effect of PDS on BG4 binding by ELISA (Supplementary Fig. S5 ). These results indicate that, at pertinent sites, PDS traps Gquadruplex structures to increase the number of BG4 targets available. This confirms earlier work proposing that small molecule ligands interact directly with cellular DNA to stabilize G-quadruplexes that, if not resolved, lead to DNA damage 5, 13 .
In summary, we have developed a highly specific DNA G-quadruplex antibody and employed it to visualize G-quadruplex structures in the DNA of human cells. We have demonstrated how the formation of G-quadruplexes is dynamically sensitive to the cell cycle, and have shown by direct visualization that a small molecule ligand traps these structures in cells. An insightful future goal would be to generate a map of the precise locations of G-quadruplex structures at a genome-wide level by sequencing. Our new findings therefore provide an important basis to help underpin recent chemical biological and genetic studies highlighting a range of potentially important biological roles of Gquadruplex structures.
Methods

Phage display selection
A single-chain antibody, BG4, was isolated from the Sanger phage display library (2.3 × 10 10 single-chain antibody clones) through selection using a panel of intramolecular Gquadruplex structures. Two rounds of selection in solution were carried out using streptavidin-coated beads (Dynabeads M-280 Streptavidin, Invitrogen) with 1 μM of biotinylated G-quadruplex oligonucleotides for the first round of selection and 100 nM for the second round. The selected binders were then cloned into the pSANG10 expression plasmid for antibody production. Screening of the selected binders was performed by DELFIA (Dissociation-Enhanced Lanthenide Fluorescent Immunoassay) using an anti-FLAG europium-conjugated antibody (Sigma) and the DELFIA reagent (Perkin Elmer). Signal intensity was detected at 615 nm with a PHERAstar microplate reader (BMG, Labtech) using Time-Resolved Fluorescence detection.
Circular dichroism (CD) spectroscopy
For CD spectroscopy, 5 μM DNA G-quadruplex oligonucleotides (listed below) were annealed in 10 mM Tris HCl, pH 7.4, 100 mM KCl by slow cooling from 95 °C to 21 °C. Five scans were performed from 200 to 320 nm using a Jasco J-810 spectropolarimeter with the buffer spectrum subtracted and zero-correction at 320 nm.
Enzyme-linked immunosorbent assay (ELISA)
ELISAs for binding affinity and specificity were performed using standard methods. Briefly, biotinylated oligonucleotides (biomers.net GmbH) were bound to streptavidin-coated plates followed by incubation with BG4 (and pyridostatin for Supplementary Fig. S5 ), and detection was achieved with an anti-FLAG horseradish peroxidase (HRP)-conjugated antibody (ab1238, Abcam, UK) and TMB (3,3′,5,5′-Tetramethylbenzidine, HRP substrate, Roche). Signal intensity was measured at 450 nm on a PHERAstar microplate reader (BMG Labtech, Germany). Dissociation constants were calculated from binding curves using GraphPad Prism (GraphPad Software, Inc.) and error bars represent standard error means calculated from 3 replicates. G-quadruplex oligonucleotides were annealed in 10 mM Tris HCl, pH 7.4, 100 mM KCl by slow cooling from 95 °C to 21 °C. For competition experiments, before assessment of BG4 binding to the MYC G-quadruplex by ELISA, BG4 was pre-incubated for 1 h at room temperature (21 °C) with 0, 1, 5, 10, 20, 50 equivalents of either KIT1 (G-quadruplex), RNA hairpin, yeast tRNA, double-stranded sonicated salmon sperm DNA, double-stranded poly(GC) n or poly(AT) n .
Cell cultures and immunofluorescence
U2OS (osteosarcoma), HeLa (cervical carcinoma), HT1080 (fibrosarcoma), MCF-7 (mammary adenocarcinoma) and MDA-MB-231 (breast carcinoma) cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) (Gibco), 1% L-glutamine, 10% FBS (fetal bovine serum); MRC-5 (fetal lung fibroblasts) cells in Minimum Essential Medium Eagle (Sigma), 10% FBS and MCF-10A (mammary epithelial) cells in Mammary Epithelial cell
Growth Medium (Lonza) with cholera toxin (at 37 °C with 5% CO 2 . Cells grown on glass coverslips were fixed in 2% paraformaldehyde/PBS or in methanol: acetic acid (3:1) ( Supplementary Fig. S3 ) and permeabilized with 0.1% triton-X100/PBS. After blocking in 2% Marvel™/PBS, immunofluorescence was performed using standard methods with BG4, anti-FLAG (#2368, Cell Signaling Technology) and anti-rabbit Alexa 594-conjugated (A11037, Invitrogen) antibodies. Coverslips were mounted with Prolong Gold/DAPI (4′,6-diamidino-2-phenylindole) (Invitrogen). For TRF2 detection, anti-TRF2 (ab13579, Abcam) and anti-mouse Alexa 488-conjugated (A11029, Invitrogen) antibodies were used. For enzyme treatments, coverslips were incubated after permeabilization with 120 U of Turbo DNase (0.12 U/μl) or 50 μg/ml of RNase A (Ambion) for 1 h at 37 °C. For pre-incubation experiments, BG4 was incubated with 20-fold excess of pre-folded DNA G-quadruplexes or single-stranded DNA oligonucleotides. Oligonucleotide transfections were performed using 200 nM pre-annealed DNA G-quadruplexes or single-stranded DNA oligonucleotides and TransIT™ Oligo Transfection Reagent (Mirus). For pyridostatin treatment, cells were incubated with 10 μM compound for 24 h. For metaphase preparations, cells were treated with colcemid (50 ng/ml) for 2 h before resuspension in 0.075 mM KCl for 30 min at 37 °C. Cells were then fixed in methanol: acetic acid (3:1) before spreading on slides. 100 wellspread metaphase chromosomes were analyzed for the number and localization of BG4 foci. For cell synchronization, MCF-7 cells were incubated for 24 h in serum-free DMEM (G0/ G1), grown for 16 h in DMEM, 20% FBS, 200 μM mimosine (G1/S), and for 3 h in DMEM, 10% FBS (S phase). Cell cycle stages were confirmed using a fluorescent activated cell sorter (FACSCalibur, BD Biosciences). To inhibit DNA replication, cells were incubated with 5 μM aphidicolin for 2 h. Digital images were recorded using a DP70 camera (Olympus) on Axioskop 2 plus microscope (Zeiss), and analyzed with Volocity software (Perkin Elmer). 100-200 nuclei were counted per condition and the standard error mean calculated from 3 replicates. Frequency distribution graphs were plotted using GraphPad Prism (GraphPad Software, Inc.).
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Refer to Web version on PubMed Central for supplementary material. After PDS treatment, a marked increase (~ 2.9-fold) in nuclear staining was observed. These results indicate that, at pertinent sites, PDS traps endogenous G-quadruplex structures to increase the number of BG4 targets available.
